top of page

This series is designed to provide investors with context to press releases directly from company management teams. It also provides the opportunity for companies to communicate directly to investors and elaborate on recent key news and highlight value driving milestones.


September 27, 2023

Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement.


September 8, 2023

AREC"s ReElement Technologies Expands Executive Team

August 24, 2023

Recent Clinical Update on Potentially Pivotal Study of Berubicin for GBM

GRI Bio Enters into Asset Purchase Agreement for Sale of Legacy Asset, ADAIR

August 23, 2023

August 7, 2023

GRI Bio Presents Encouraging Preclinical Data of GRI-0803 in Lupus Nephritis

Access, Ideas, Clarity

A leading virtual platform providing investors with direct access to innovative companies, management teams and thought leaders

What This Means:

Contat Us
bottom of page